183 related articles for article (PubMed ID: 20823492)
21. Cytotoxicity and apoptotic activities of alpha-, gamma- and delta-tocotrienol isomers on human cancer cells.
Lim SW; Loh HS; Ting KN; Bradshaw TD; Zeenathul NA
BMC Complement Altern Med; 2014 Dec; 14():469. PubMed ID: 25480449
[TBL] [Abstract][Full Text] [Related]
22. Tocotrienol and cancer metastasis.
De Silva L; Chuah LH; Meganathan P; Fu JY
Biofactors; 2016; 42(2):149-62. PubMed ID: 26948691
[TBL] [Abstract][Full Text] [Related]
23. Antiangiogenic and anticancer potential of unsaturated vitamin E (tocotrienol).
Miyazawa T; Shibata A; Sookwong P; Kawakami Y; Eitsuka T; Asai A; Oikawa S; Nakagawa K
J Nutr Biochem; 2009 Feb; 20(2):79-86. PubMed ID: 19071006
[TBL] [Abstract][Full Text] [Related]
24. Chemoprevention of tocotrienols: the mechanism of antiproliferative effects.
Wada S
Forum Nutr; 2009; 61():204-216. PubMed ID: 19367124
[TBL] [Abstract][Full Text] [Related]
25. Tocotrienols potentiate lovastatin-mediated growth suppression in vitro and in vivo.
McAnally JA; Gupta J; Sodhani S; Bravo L; Mo H
Exp Biol Med (Maywood); 2007 Apr; 232(4):523-31. PubMed ID: 17392488
[TBL] [Abstract][Full Text] [Related]
26. Tocotrienols: The promising analogues of vitamin E for cancer therapeutics.
Sailo BL; Banik K; Padmavathi G; Javadi M; Bordoloi D; Kunnumakkara AB
Pharmacol Res; 2018 Apr; 130():259-272. PubMed ID: 29496592
[TBL] [Abstract][Full Text] [Related]
27. Tocotrienol: the natural vitamin E to defend the nervous system?
Sen CK; Khanna S; Roy S
Ann N Y Acad Sci; 2004 Dec; 1031():127-42. PubMed ID: 15753140
[TBL] [Abstract][Full Text] [Related]
28. Vitamin E tocotrienols improve insulin sensitivity through activating peroxisome proliferator-activated receptors.
Fang F; Kang Z; Wong C
Mol Nutr Food Res; 2010 Mar; 54(3):345-52. PubMed ID: 19866471
[TBL] [Abstract][Full Text] [Related]
29. Do tocotrienols have potential as neuroprotective dietary factors?
Frank J; Chin XW; Schrader C; Eckert GP; Rimbach G
Ageing Res Rev; 2012 Jan; 11(1):163-80. PubMed ID: 21763788
[TBL] [Abstract][Full Text] [Related]
30. Tumor suppressive effects of tocotrienol in vivo and in vitro.
Wada S; Satomi Y; Murakoshi M; Noguchi N; Yoshikawa T; Nishino H
Cancer Lett; 2005 Nov; 229(2):181-91. PubMed ID: 16098658
[TBL] [Abstract][Full Text] [Related]
31. A naturally occurring mixture of tocotrienols inhibits the growth of human prostate tumor, associated with epigenetic modifications of cyclin-dependent kinase inhibitors p21 and p27.
Huang Y; Wu R; Su ZY; Guo Y; Zheng X; Yang CS; Kong AN
J Nutr Biochem; 2017 Feb; 40():155-163. PubMed ID: 27889685
[TBL] [Abstract][Full Text] [Related]
32. Revisiting the therapeutic potential of tocotrienol.
Ranasinghe R; Mathai M; Zulli A
Biofactors; 2022 Jul; 48(4):813-856. PubMed ID: 35719120
[TBL] [Abstract][Full Text] [Related]
33. Vitamin E and cancer: an update on the emerging role of γ and δ tocotrienols.
Constantinou C; Charalambous C; Kanakis D
Eur J Nutr; 2020 Apr; 59(3):845-857. PubMed ID: 31016386
[TBL] [Abstract][Full Text] [Related]
34. Redox-inactive analogue of tocotrienol as a potential anti-cancer agent.
Yano T; Sato A; Sekine M; Virgona N; Ota M
Anticancer Agents Med Chem; 2013 Mar; 13(3):496-501. PubMed ID: 22721395
[TBL] [Abstract][Full Text] [Related]
35. Improved antitumor activity and reduced cardiotoxicity of epirubicin using hepatocyte-targeted nanoparticles combined with tocotrienols against hepatocellular carcinoma in mice.
Nasr M; Nafee N; Saad H; Kazem A
Eur J Pharm Biopharm; 2014 Sep; 88(1):216-25. PubMed ID: 24813390
[TBL] [Abstract][Full Text] [Related]
36. Novel tocotrienol-entrapping vesicles can eradicate solid tumors after intravenous administration.
Fu JY; Zhang W; Blatchford DR; Tetley L; McConnell G; Dufès C
J Control Release; 2011 Aug; 154(1):20-6. PubMed ID: 21539872
[TBL] [Abstract][Full Text] [Related]
37. PEGylated γ-tocotrienol isomer of vitamin E: Synthesis, characterization, in vitro cytotoxicity, and oral bioavailability.
Abu-Fayyad A; Behery F; Sallam AA; Alqahtani S; Ebrahim H; El Sayed KA; Kaddoumi A; Sylvester PW; Carroll JL; Cardelli JA; Nazzal S
Eur J Pharm Biopharm; 2015 Oct; 96():185-95. PubMed ID: 26235392
[TBL] [Abstract][Full Text] [Related]
38. Molecular Mechanisms of Action of Tocotrienols in Cancer: Recent Trends and Advancements.
Aggarwal V; Kashyap D; Sak K; Tuli HS; Jain A; Chaudhary A; Garg VK; Sethi G; Yerer MB
Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30717416
[TBL] [Abstract][Full Text] [Related]
39. Tocotrienol Nanoemulsion Platform of Curcumin Elicit Elevated Apoptosis and Augmentation of Anticancer Efficacy against Breast and Ovarian Carcinomas.
Steuber N; Vo K; Wadhwa R; Birch J; Iacoban P; Chavez P; Elbayoumi TA
Int J Mol Sci; 2016 Oct; 17(11):. PubMed ID: 27792193
[TBL] [Abstract][Full Text] [Related]
40. A review on the use of statins and tocotrienols, individually or in combination for the treatment of osteoporosis.
Abdul-Majeed S; Mohamed N; Soelaiman IN
Curr Drug Targets; 2013 Dec; 14(13):1579-90. PubMed ID: 23848479
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
